Refine by
Clinical Medicine Articles & Analysis
90 news found
Laser therapy is transforming clinical medicine, offering innovative solutions for skin therapy, cervical surgery, and gynecological procedures. ...
The two companies collaborated with precision medicine clinical research organization (CRO) Precision for Medicine, which contributes its state-of-the-art, CAP-accredited, CLIA-certified laboratory services to Boundless Bio’s POTENTIATE Phase 1/2 clinical trial by successfully validating a proprietary workflow to process ...
According to University of Arizona clinical professor of medicine and dream specialist, Rubin Naiman, PhD, the two key components of good sleep quality are non-REM and REM sleep. ...
Phase 1 studies show improvement in cognitive factors, consistent with therapeutic potential of CY6463 to improve key features in neurological diseases CY6463 favorable tolerability and safety profile was confirmed Ariana Pharma, a leading Artificial Intelligence (AI) drug development company, in collaboration with Cyclerion Therapeutics, presented today safety and pharmacodynamic results ...
Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has adopted PRAC’s recommendation to add measures to minimise risk of serious side effects with JAK inhibitors for chronic inflammatory disorders. ...
Regor Therapeutics, a clinical-stage biotech company, announced today the Investigational New Drug (IND) Application for RGT-264 phosphate tablet, a small molecular selective hematopoietic progenitor kinase (HPK1) inhibitor has been approved by the National Medical Products Administration (NMPA) of China. ...
These results thus far illustrate BioMark’s continuous efforts to diversify its product portfolio, expand its clinical application toward personalized medicine and patent portfolio with new discoveries that can impact cancer care management. We at BioMark invest in the right science to have trusted clinical outcomes,” says Rashid Bux, ...
Ariana Pharma, the leading Al-driven precision medicine company, has announced the first comprehensive blarcamesine pathway analysis impact using extensive data from the ANAVEX®2-73-PDD-001 Parkinson’s Disease Dementia (PDD) clinical study. Initial results were presented by Ariana Pharma at the Alzheimer’s Association International Conference ...
Fractional laser is a commonly used instrument in clinical beauty medicine. In addition to treating acne scars, burn scars, and trauma scars, it also has a good effect on facial rejuvenation, freckle removal, skin shrinking, and stretch marks. ...
Updated 12-month results from the open-label investigator-initated Phase II clinical trial GADinLADA that assessed three intralymphatic injections of the therapeutic diabetes vaccine Diamyd® in individuals diagnosed with Latent Autoimmune Diabetes in Adults (LADA) were presented today at the European Association for the Study of Diabetes (EASD) conference in Stockholm, ...
Our partners include Puerto Rico Urological Group, Empresas River Siaca, Grupo Ferré Rangel, D Group Equities Management Corp., ZERO - The End of Prostate Cancer, Fans for the Cure, Puerto Rico Consortium for Clinical Investigation, Partnership for Modern Puerto Rico, Synercode, PR5G, Health Front Group, Puerto Rico Federal Affairs and Administration, and San Juan Bautista ...
Analyses also showed a positive immunological response to the treatment and the clinical course appeared promising with all individuals remaining insulin-independent 12 months after treatment. ...
Ariana Pharma, the leading eXplainable Artificial Intelligence (xAI) drug development company, announce the appointments of Dr. Marion Soto as Vice President, Business Development and Bertrand Lellouche as Chief Financial Officer. The financial and commercial experience of Marion and Bertrand will further drive Ariana’s accelerated growth. Marion and Bertrand will be bringing their ...
(NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company focused on developing cost-effective, rapid, near-patient tests for triage and monitoring of disease progression, today announced that positive results of analytical and clinical studies of Bluejay’s Symphony IL-6 Test were presented at AACC 2022, the leading industry ...
A distinguished professor of medicine, clinical cardiologist, and researcher focused on cardiovascular imaging and prevention, Dr. Villines is board-certified in internal medicine, cardiovascular diseases, cardiac computed tomography, and advanced adult echocardiography. ...
ByElucid
DocPanel will leverage Intuition’s KLAS-leading clinical features, plus a growing list of exclusive subscription-only content, accelerate their CT and MRI interpretation capabilities and, in turn, bolster their sub-specialty reading services to radiology and physician groups, hospitals, and occupational medicine clinics. ...
Analyses also showed a positive immunological response to the treatment and the clinical course appears promising with all individuals remaining insulin-independent 12 months after treatment. ...
ESO-101 is currently being investigated in the Phase II ACESO clinical trial in eosinophilic esophagitis (EoE) in four European countries. ...
3DBio Therapeutics (3DBio), a clinical-stage regenerative medicine company, and the Microtia-Congenital Ear Deformity Institute announced they have conducted a human ear reconstruction using the AuriNovo™ implant, an investigational, patient-matched, 3D-bioprinted living tissue ear implant. The groundbreaking reconstructive procedure in the first-in-human ...
The promising results of the first clinical study on SILKBridge® conducted by Prof. Maurizio Calcagni, Deputy Clinic Director at Department of Plastic Surgery and Hand Surgery at University Hospital Zurich, will be presented on Tuesday, June 7 at 11:30 London time at ExCeL Conference Centre in Room 5 Surgeon – South Gallery room 7-10 during the 2022 ...
ByKLISBio